Frozen Shoulder Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Frozen Shoulder Syndrome Clinical Trials Market Overview
The Frozen Shoulder Syndrome clinical trial market research report provides an overview of the Frozen Shoulder Syndrome Clinical trials scenario. This report provides top-line data relating to the clinical trials on Frozen Shoulder Syndrome. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials (based on the number of ongoing trials).
Key Regions | · Asia-Pacific
· Europe · North America · Middle East & Africa · South & Central America |
Key Countries | · China
· India · Russia · Iran · The US · South Korea · Taiwan · Japan · Egypt · The UK |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Endo International Plc
· Hunan Jiudian Pharmaceutical Co Ltd · Dompe Farmaceutici SpA · GSK plc · 180 Life Sciences Corp · Anhui Anke Yu Liang Qing Pharmaceutical Co Ltd · Berezovskiy Pharmaceutical Plant · Bluefish Pharmaceuticals AB · Disha Pharmaceutical Group Co Ltd · ICBio Clinical Research Pvt Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Frozen Shoulder Syndrome Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Frozen Shoulder Syndrome clinical trials market are Asia-Pacific, Europe, North America, the Middle East & Africa, and South & Central America, among others. The Asia-Pacific region dominates the market as of June 2023.
In a country-wise analysis, as of June 2023, China has the highest number of Frozen Shoulder Syndrome clinical trials, followed by India, Russia, Iran, the US, South Korea, Taiwan, Japan, Egypt, and the UK.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the UK has the highest proportion of Frozen Shoulder Syndrome to Musculoskeletal Disorders clinical trials as of June 2023. Moreover, majority of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of Frozen Shoulder Syndrome to Musculoskeletal Disorders clinical trials as of June 2023. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Frozen Shoulder Syndrome Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Frozen Shoulder Syndrome clinical trials market, download a free report sample
Frozen Shoulder Syndrome Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Frozen Shoulder Syndrome clinical trials market are institution, company, and the government. Out of them, the institution sponsor type dominates the market.
Frozen Shoulder Syndrome Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Frozen Shoulder Syndrome clinical trials market, download a free report sample
Frozen Shoulder Syndrome Clinical Trials Market - Competitive Landscape
The leading sponsors in the Frozen Shoulder Syndrome clinical trials market are Endo International Plc, Hunan Jiudian Pharmaceutical Co Ltd, Dompe Farmaceutici SpA, GSK plc, 180 Life Sciences Corp, Anhui Anke Yu Liang Qing Pharmaceutical Co Ltd, Berezovskiy Pharmaceutical Plant, Bluefish Pharmaceuticals AB, Disha Pharmaceutical Group Co Ltd, and ICBio Clinical Research Pvt Ltd. Endo International Plc led the Frozen Shoulder Syndrome clinical trials market in June 2023.
Frozen Shoulder Syndrome Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading sponsors in the Frozen Shoulder Syndrome clinical trials market, download a free report sample
Segments Covered in the Report
Frozen Shoulder Syndrome Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East & Africa
- South & Central America
Frozen Shoulder Syndrome Clinical Trials Country Outlook (2023)
- China
- India
- Russia
- Iran
- The US
- South Korea
- Taiwan
- Japan
- Egypt
- The UK
Frozen Shoulder Syndrome Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, and End point status
- The report reviews the top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended, and Withdrawn) with a reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Hunan Jiudian Pharmaceutical Co Ltd
Dompe Farmaceutici SpA
GSK plc
180 Life Sciences Corp
Anhui Anke Yu Liang Qing Pharmaceutical Co Ltd
Berezovskiy Pharmaceutical Plant
Bluefish Pharmaceuticals AB
Disha Pharmaceutical Group Co Ltd
ICBio Clinical Research Pvt Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which is the leading region in the Frozen Shoulder Syndrome clinical trials market?
Asia-Pacific is the leading region in the Frozen Shoulder Syndrome clinical trials market as of June 2023.
-
Which is the leading country in the Frozen Shoulder Syndrome clinical trials market?
China is the leading country in the Frozen Shoulder Syndrome clinical trials market as of June 2023.
-
Which is the leading sponsor type in the Frozen Shoulder Syndrome clinical trials market?
Institution is the leading sponsor type in the Frozen Shoulder Syndrome clinical trials market as of June 2023.
-
Who are the leading sponsors in the Frozen Shoulder Syndrome clinical trials market?
The leading sponsors in the Frozen Shoulder Syndrome clinical trials market are Endo International Plc, Hunan Jiudian Pharmaceutical Co Ltd, Dompe Farmaceutici SpA, GSK plc, 180 Life Sciences Corp, Anhui Anke Yu Liang Qing Pharmaceutical Co Ltd, Berezovskiy Pharmaceutical Plant, Bluefish Pharmaceuticals AB, Disha Pharmaceutical Group Co Ltd, and ICBio Clinical Research Pvt Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.